Drugs are being developed to target specific patients’ tumours, but the systems to deliver them to the patients who will benefit the most is lagging behind, says one of the country’s top medical specialists. Winifred Robinson finds out how DNA tests could help prolong the life of people with incurable cancer if only the NHS had a framework to deliver them nationally.
Disclaimer
The ´óÏó´«Ã½ is not responsible for the content of external websites.
